Researchers are using single-cell polygenic risk scores and multiomic approaches to study the cellular and molecular heterogeneity of complex human diseases. This involves dissecting the mechanisms underlying diseases such as Alzheimer's, schizophrenia, and lupus at the single-cell level. The goal of these studies appears to be identifying novel therapeutic targets and understanding the underlying genetic and molecular associations of these diseases.